glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs
Pay in 4 interest-free payments of $7.37 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://www.researchgate.net/publication/396199809/figure/fig1/AS:11431281662477866@1759630049049/The-therapeutic-mechanism-of-GLP-1RAs-in-the-treatment-of-HS_Q320.jpg)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://cdn.myhealthteams.com/graphic/69947cbfb8f54b175fbb423f/woriginal/glp1_injection-62d07be9d309baeaf211e67f84e4364b.webp?1771338942)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://jcadonline.com/wp-content/uploads/Cotter2_Table2.gif)
![glp-1 and hs Translated article] Glucagon-Like Peptide-1 Agonists for Treating Obesity in Patients With Immune-Mediated Skin Diseases The therapeutic mechanism of GLP-1RAs](https://jddonline.com/wp-content/uploads/2025/04/JDD-BLOG-IMAGE-TEMPLATE-2.png)

























